| Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs L Kumari, Y Choudhari, P Patel, GD Gupta, D Singh, JM Rosenholm, ... Life 13 (5), 1099, 2023 | 94 | 2023 |
| Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches V Asati, A Anant, P Patel, K Kaur, GD Gupta European Journal of Medicinal Chemistry 225, 113781, 2021 | 52 | 2021 |
| Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology BD Kurmi, P Patel, R Paliwal, SR Paliwal Journal of drug delivery science and technology 57, 101682, 2020 | 50 | 2020 |
| Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent VK Patel, E Shirbhate, P Patel, R Veerasamy, PC Sharma, H Rajak Beni-Suef University journal of basic and applied sciences 10, 1-13, 2021 | 43 | 2021 |
| Panobinostat as pan-deacetylase inhibitor for the treatment of pancreatic cancer: recent progress and future prospects A Singh, VK Patel, DK Jain, P Patel, H Rajak Oncology and therapy 4, 73-89, 2016 | 41 | 2016 |
| Synthesis, characterization and in vivo evaluation of PEGylated PPI dendrimer for safe and prolonged delivery of insulin AK Parashar, P Patel, AK Gupta, NK Jain, BD Kurmi Drug Delivery Letters 9 (3), 248-263, 2019 | 37 | 2019 |
| The safety, efficacy and therapeutic potential of histone deacetylase inhibitors with special reference to panobinostat in gastrointestinal tumors: a review of preclinical and … A Singh, P Patel, Jageshwar, VK Patel, DK Jain, M Kamal, H Rajak Current cancer drug targets 18 (8), 720-736, 2018 | 26 | 2018 |
| Recent progress in histone deacetylase (HDAC) 1 inhibitors as anticancer agent P Patel, SK Wahan, S Vishakha, BD Kurmi, GD Gupta, H Rajak, V Asati Current Cancer Drug Targets 23 (1), 47-70, 2023 | 23 | 2023 |
| Emerging targeted therapeutic strategies for the treatment of triple-negative breast cancer L Kumari, L Mishra, P Patel, N Sharma, GD Gupta, BD Kurmi Journal of drug targeting 31 (9), 889-907, 2023 | 21 | 2023 |
| Pharmacophore based 3D-QSAR, virtual screening and docking studies on novel series of HDAC inhibitors with thiophen linker as anticancer agents P Patel, A Singh, V K Patel, D K Jain, R Veerasamy, H Rajak Combinatorial chemistry & high throughput screening 19 (9), 735-751, 2016 | 21 | 2016 |
| Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies M Kaur, S Misra, P Swarnkar, P Patel, BD Kurmi, GD Gupta, A Singh Biochemical Pharmacology 215, 115723, 2023 | 20 | 2023 |
| The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment E Shirbhate, P Patel, VK Patel, R Veerasamy, PC Sharma, H Rajak Future Oncology 16 (30), 2457-2469, 2020 | 20 | 2020 |
| Histone deacetylase inhibitors for the treatment of colorectal cancer: Recent progress and future prospects A Singh, P Patel, V K Patel, D K Jain, R Veerasamy, P C Sharma, H Rajak Current cancer drug targets 17 (5), 456-466, 2017 | 20 | 2017 |
| Recent updates on structural insights of MAO-B inhibitors: A review on target-based approach GS Baweja, S Gupta, B Kumar, P Patel, V Asati Molecular Diversity 28 (3), 1823-1845, 2024 | 19 | 2024 |
| Exploring metal-organic frameworks (MOFs) in drug delivery: A concise overview of synthesis approaches, versatile applications, and current challenges BDK Akash Vikal a 1 , Rashmi Maurya a 1 , Preeti Patel b c , Shivani Rai ... Applied Materials Today 41 (https://doi.org/10.1016/j.apmt.2024.1024), 102443, 2024 | 16 | 2024 |
| Alternatives of animal models for biomedical research: a comprehensive review of modern approaches A Vashishat, P Patel, G Das Gupta, B Das Kurmi Stem Cell Reviews and Reports 20 (4), 881-899, 2024 | 16 | 2024 |
| Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studies VK Patel, A Singh, DK Jain, P Patel, R Veerasamy, PC Sharma, H Rajak Future Journal of Pharmaceutical Sciences 3 (2), 71-78, 2017 | 16 | 2017 |
| Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date) P Patel, R Shakya, V Asati, BD Kurmi, SK Verma, GD Gupta, H Rajak Journal of Molecular Structure 1299, 137098, 2024 | 14 | 2024 |
| Solid Lipid Nanoparticles (SLNs): Advancements in modification strategies toward drug delivery vehicle GMH Al-Sayadi, A Verma, Y Choudhary, P Sandal, P Patel, D Singh, ... Pharmaceutical nanotechnology 11 (2), 138-154, 2023 | 14 | 2023 |
| Novel VEGFR-2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021) PP Vishakha S., Kumari Kajal, Sitanshu Mondal, Simranpreet K. Wahan, Balak ... Chemistry and Biodiversity, https://doi.org/10.1002/cbdv.202200847, 2023 | 14* | 2023 |
Dr. Balak Das KurmiDepartment of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga-142001, INDIAبريد إلكتروني تم التحقق منه على isfcp.org